Industry Biotechnology (See Other Companies in Industry)
215 First Street Suite 240| Date | Filing Type | Offered | Sold | Type | Link to Raw Filing |
|---|---|---|---|---|---|
| 2013-03-28 | New Form D | Offered: $34,999,920 | Sold: $34,999,920 | Type: Equity Only | Raw Filing |
| 2012-08-14 | Amended | Offered: $4,936,547 | Sold: $4,936,547 | Type: Equity Only | Raw Filing |
| 2012-08-03 | Amended | Offered: $4,077,409 | Sold: $4,077,409 | Type: Equity Only | Raw Filing |
| 2012-07-20 | Amended | Offered: $3,635,946 | Sold: $3,635,946 | Type: Equity Only | Raw Filing |
| 2012-07-05 | New Form D | Offered: $1,403,622 | Sold: $1,403,622 | Type: Equity Only | Raw Filing |
| 2012-04-09 | New Form D | Offered: $37,238,097 | Sold: $37,238,097 | Type: Equity Only | Raw Filing |
| Name | Role | Address |
|---|---|---|
| Richard Aldrich | Director | 215 First Street Suite 240 Cambridge, MA, 02142 |
| Christopher A. Bleck | Executive | 215 First Street Suite 240 Cambridge, MA, 02142 |
| Jeff Capello | Director | 215 First Street Suite 240 Cambridge, MA, 02142 |
| Scott Chappel | Executive | 215 First Street Suite 240 Cambridge, MA, 02142 |
| Michelle Dipp | Director, Executive | 215 First Street Suite 240 Cambridge, MA, 02142 |
| Michael Flanagan | Executive | 800 Boylston Street Suite 1555 Boston, MA, 02199 |
| Stephen Kraus | Director | 215 First Street Suite 240 Cambridge, MA, 02142 |
| Alison Lawton | Executive | 215 First Street Suite 240 Cambridge, MA, 02142 |
| Thomas Malley | Director | 215 First Street Suite 240 Cambridge, MA, 02142 |
| John Simon | Director | 215 First Street Suite 240 Cambridge, MA, 02142 |
| Harald Stock | Director | 215 First Street Suite 240 Cambridge, MA, 02142 |
| Jonathan Tilly | Director | 215 First Street Suite 240 Cambridge, MA, 02142 |
| Christoph Westphal | Director | 215 First Street Suite 240 Cambridge, MA, 02142 |